PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.751
https://www.valueinhealthjournal.com/article/S1098-3015(12)00816-9/fulltext
Title : PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00816-9&doi=10.1016/j.jval.2012.03.751
First page : A139
Section Title : Gastrointestinal Disorders
Open access? : No
Section Order : 227
Categories :
Tags :
Regions :
ViH Article Tags :